Treace Medical Concepts (TMCI) Shares Outstanding (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Shares Outstanding (Entity) came in at $64.8 million in Q1 2026, up 3.01% YoY from $62.9 million in Q1 2025, and up 1.44% on a QoQ basis from $63.9 million in Q4 2025.
Treace Medical Concepts (TMCI) Shares Outstanding (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Shares Outstanding (Entity) data on file, last reported at $64.8 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 3.01% year-over-year to $64.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.8 million (up 3.01% YoY) and the FY2025 annual result came in at $63.9 million, up 2.41% from the prior year.
- Shares Outstanding (Entity) rose to $64.8 million in Q1 2026, from $63.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $64.8 million in Q1 2026 to a low of $55.3 million in Q1 2022.
- A 5-year average of $60.9 million and a median of $61.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 45.25% — and 2024, when it advanced 0.99%.
- Tracing TMCI's Shares Outstanding (Entity) over 5 years: stood at $55.6 million in 2022, then gained by 11.0% to $61.7 million in 2023, then gained by 0.99% to $62.4 million in 2024, then rose by 2.41% to $63.9 million in 2025, then increased by 1.44% to $64.8 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $64.8 million (Q1 2026), $63.9 million (Q4 2025), and $63.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Treace Medical Concepts | 284.92 Mn | 239.30 Mn | 35.61 Mn | 65.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.05 Mn |
| Mar 31, 2026 | 64.59 Mn |
| Dec 31, 2025 | 63.27 Mn |
| Sep 30, 2025 | 63.52 Mn |
| Jun 30, 2025 | 63.01 Mn |
| Mar 31, 2025 | 62.66 Mn |
| Dec 31, 2024 | 62.11 Mn |
| Sep 30, 2024 | 62.23 Mn |
| Jun 30, 2024 | 62.08 Mn |
| Mar 31, 2024 | 61.79 Mn |
| Dec 31, 2023 | 60.85 Mn |
| Sep 30, 2023 | 61.56 Mn |
| Jun 30, 2023 | 61.38 Mn |
| Mar 31, 2023 | 58.72 Mn |
| Dec 31, 2022 | 55.28 Mn |
| Sep 30, 2022 | 55.43 Mn |
| Jun 30, 2022 | 55.31 Mn |
| Mar 31, 2022 | 54.83 Mn |
| Dec 31, 2021 | 48.42 Mn |
| Sep 30, 2021 | 52.77 Mn |